Princeton, NJ | Newtown, PA | Freehold, NJ
Also known as: mdbpartners
Michael D. Becker, president and founder of MDB Communications LLC, has more than -years of experience as a serial entrepreneur, C-level industry executive, drug developer, Wall Street securities analyst and registered financial advisor. He has authored original articles on medical, financial, communications, marketing, and regulatory topics relevant to the biotechnology, pharmaceutical, and medical device industries and is widely quoted by the press. Before establishing MDB Communications LLC in June , he was founder and managing partner of the successful consulting firm MD Becker Partners LLC from -. He also previously served as president, chief executive officer, and member of the Board of Directors for several publicly-traded biotechnology companies including commercial-stage Cytogen Corporation (acquired by EUSA Pharma) and development-stage VioQuest Pharmaceuticals, Inc. Mr. Becker held positions of increasing responsibility prior to being appointed President and CEO of Cytogen in , including Vice President of Business Development, Industry Relations, Investor Relations and Chief Executive Officer of AxCell Biosciences, a subsidiary of Cytogen focused on signal transduction pathways. During his tenure at Cytogen, Mr. Becker raised in excess of million in new capital through both public offerings and private placements and in-licensed Caphosol, a topical oral agent and prescription medical device for the treatment of oral mucositis and xerostomia. Specialties capital raising, investor relations, business development, oncology product commercialization, medical devices, supportive care, merger and acquisition, strategic planning, clinical development
